OBE022, an Oral and Selective Prostaglandin F2α Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2018-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1124/jpet.118.247668PMID 29777040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• First-in-Human Study

  2020cited by this paper
• In-Vitro Characterization of mCerulean3_mRuby3 as a Novel FRET Pair with Favorable Bleed-Through Characteristics

  2019cited by this paper
• Impact of G protein-coupled receptor heteromers in endocrine systems.

  2017cited by this paper
• Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis.

  2015cited by this paper
• EP2 receptor activates dual G protein signaling pathways that mediate contrasting proinflammatory and relaxatory responses in term pregnant human myometrium.

  2014cited by this paper
• A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrhea.

  2014cited by this paper
• Prostaglandin E2 Inhibits Elastogenesis in the Ductus Arteriosus via EP4 Signaling

  2014influential reference
• PGE2 through the EP4 receptor controls smooth muscle gene expression patterns in the ductus arteriosus critical for remodeling at birth.

  2012cited by this paper
• The roles of prostaglandin EP 1 and 3 receptors in the control of human myometrial contractility.

  2012cited by this paper
• Targeting the prostaglandin F2α receptor for preventing preterm labor with azapeptide tocolytics.

  2011cited by this paper
• A Novel Biased Allosteric Compound Inhibitor of Parturition Selectively Impedes the Prostaglandin F2α-mediated Rho/ROCK Signaling Pathway*

  2010cited by this paper
• Biological Significance of GPCR Heteromerization in the Neuro-Endocrine System

  2010cited by this paper
• Tocolytic Therapy: A Meta-Analysis and Decision Analysis

  2009cited by this paper
• HTRF: A Technology Tailored for Drug Discovery –A Review of Theoretical Aspects and Recent Applications

  2009influential reference
• Developments in the pharmacotherapeutic management of spontaneous preterm labor

  2008cited by this paper
• Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors

  2008cited by this paper
• Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour.

  2007cited by this paper
• Arrest of preterm labor in rat and mouse by an oral and selective nonprostanoid antagonist of the prostaglandin F2alpha receptor (FP).

  2007cited by this paper
• Inhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice.

  2006influential reference
• Constriction of the ductus arteriosus by selective inhibition of cyclooxygenase-1 and -2 in near-term and preterm fetal rats.

  2006influential reference
• Regional Expression of Prostaglandin E2 and F2alpha Receptors in Human Myometrium, Amnion, and Choriodecidua with Advancing Gestation and Labor1

  2006cited by this paper
• Delay of preterm birth in sheep by THG113.31, a prostaglandin F2alpha receptor antagonist.

  2005cited by this paper
• The Promise of Prostaglandins: Have They Fulfilled Their Potential as Therapeutic Targets for the Delay of Preterm Birth?

  2005cited by this paper
• Specific PGF2α receptor (FP) antagonism and human uterine contractility in vitro

  2005influential reference
• Preterm delivery

  2005cited by this paper
• Nimesulide, a Cyclooxygenase-2 Preferential Inhibitor, Impairs Renal Function in the Newborn Rabbit

  2004cited by this paper
• Expression, localization and function of prostaglandin receptors in myometrium.

  2004cited by this paper
• Prostaglandin F2α, cytokines, and cyclic mechanical stretch augment matrix metalloproteinase-1 secretion from cultured human uterine cervical fibroblast cells

  2004cited by this paper
• A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor.

  2003cited by this paper
• Prostaglandin inhibitors in preterm labour.

  2003influential reference
• Pharmacology of (2S,4Z)-N-[(2S)-2-Hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2′-methyl[1,1′-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a New Potent and Selective Nonpeptide Antagonist of the Oxytocin Receptor

  2003cited by this paper
• Expression of prostanoid receptors in human lower segment pregnant myometrium.

  2003cited by this paper
• Prostaglandins and mechanisms of preterm birth.

  2002cited by this paper
• Prostaglandins and Prostanoid Receptors in Human Pregnancy and Parturition

  2002cited by this paper
• Prostaglandin F(2alpha), cytokines and cyclic mechanical stretch augment matrix metalloproteinase-1 secretion from cultured human uterine cervical fibroblast cells.

  2002cited by this paper
• The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit.

  2002cited by this paper
• THG113: a novel selective FP antagonist that delays preterm labor.

  2002cited by this paper
• Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term decidua and fetal membranes: the effect of prostaglandin F(2alpha) and indomethacin.

  2001cited by this paper
• Prostaglandin receptors: their role in regulating renal function.

  2000cited by this paper
• The Renal Hemodynamic Effects of Ibuprofen in the Newborn Rabbit

  2000cited by this paper
• Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic.

  1999cited by this paper
• The pharmacology of the ductus arteriosus.

  1998cited by this paper
• Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice.

  1998cited by this paper
• Teratogen update: fetal effects of indomethacin administration during pregnancy.

  1997cited by this paper
• Failure of parturition in mice lacking the prostaglandin F receptor.

  1997cited by this paper
• Acute renal failure in the neonate induced by the administration of indomethacin as a tocolytic agent.

  1996cited by this paper
• In vitro characterization of prostanoid receptors on human myometrium at term pregnancy

  1993cited by this paper
• Indomethacin as an inhibitor of preterm labor. Effect on postnatal renal function.

  1988cited by this paper
• Indomethacin as an Inhibitor of Preterm Labor

  1988cited by this paper
• In Vivo Constriction of the Ductus Arteriosus by Nonsteroidal Antiinflammatory Drugs in Near-Term and Preterm Fetal Rats

  1987cited by this paper
• Effects of the antiprogesterone RU 486 on preterm birth in the rat.

  1987cited by this paper
• Study of oxytocin receptor: II. oxytocin and prostaglandin F2 alpha receptors in human myometria and amnion-decidua complex during pregnancy and labor.

  1984cited by this paper
• Induction of labor with low-dose prostaglandin F2α and oxytocin

  1980cited by this paper
• Induction of labor with low-dose prostaglandin F2 alpha and oxytocin.

  1980cited by this paper

• Preventing Preterm Birth: The Search for Tocolytic Synergism

  2025influential citation
• Modern possibilities and prospects of tocolytic therapy

  2024cites this paper
• Preventing Preterm Birth: Exploring Innovative Solutions.

  2024cites this paper
• Arrest of mouse preterm labor until term delivery by combination therapy with atosiban and mundulone, a natural product with tocolytic efficacy

  2023cites this paper
• Addressing a Broken Drug Pipeline for Preterm Birth: Why Early Preterm Birth is an Orphan Disease.

  2023cites this paper
• Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium

  2023cites this paper
• Disruption of Prostaglandin F2α Receptor Signaling Attenuates Fibrotic Remodeling and Alters Fibroblast Population Dynamics in A Preclinical Murine Model of Idiopathic Pulmonary Fibrosis

  2023influential citation
• Arrest of mouse preterm labor until term delivery by combination therapy with atosiban and mundulone, a natural product with tocolytic efficacy

  2023cites this paper
• PGF2α induces a pro-labour phenotypical switch in human myometrial cells that can be inhibited with PGF2α receptor antagonists

  2023cites this paper
• PGF2α signaling drives fibrotic remodeling and fibroblast population dynamics in mice

  2023cites this paper
• Clarithromycin prevents preterm birth and neonatal mortality by dampening alarmin-induced maternal–fetal inflammation in mice

  2022cites this paper
• Preterm Birth Therapies to Target Inflammation

  2022cites this paper
• Impact of prolonged use of adjuvant tocolytics after cervical cerclage on late abortion and premature delivery

  2022cites this paper
• PGF2α facilitates pathological retinal angiogenesis by modulating endothelial FOS‐driven ELR + CXC chemokine expression

  2022cites this paper
• Maternal and neonatal outcomes of pregnancy complicated by urolithiasis: a systematic review and meta-analysis

  2021cites this paper
• Landscape of Preterm Birth Therapeutics and a Path Forward

  2021influential citation
• The determinant role of IL-6 in the establishment of inflammation leading to spontaneous preterm birth.

  2021cites this paper
• Contraction-associated proteins expression by human uterine smooth muscle cells depends on maternal serum and progranulin associated with gestational weight gain.

  2020cites this paper
• Drug discovery strategies for the identification of novel regulators of uterine contractility.

  2020cites this paper
• Efficient Design of Integrated and Adaptively Interlinked Protocols for Early-Phase Drug Development Programs

  2020cites this paper
• A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action

  2020influential citation
• Pharmacology for Preterm Labor.

  2020cites this paper
• Efficient Design of Integrated and Adaptively Interlinked Protocols for Early-Phase Drug Development Programs.

  2019cites this paper
• Safety and Efficacy of Tocolytics for the Treatment of Spontaneous Preterm Labour.

  2019cites this paper
• Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone

  2019cites this paper
• Functional Hierarchy of Uterotonics Required for Successful Parturition in Mice

  2019cites this paper
• Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways

  2019cites this paper